Immediate Impact
3 standout
Citing Papers
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside
2024 Standout
Molecular Mechanisms in Autoimmune Thyroid Disease
2023 Standout
Works of John Larry being referenced
Tolerance of Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) Inhibitors in Patients With Self-Reported Statin Intolerance
2018
Bullous pemphigoid after treatment with furosemide
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| John Larry | 6 | 11 | 13 | 10 | 6 | 27 | ||
| Jean D. Benedict | 14 | 75 | 9 | 9 | 27 | 5 | 192 | |
| R. Baggio | 5 | 6 | 4 | 7 | 6 | 31 | ||
| Rachel S. Fletcher | 5 | 9 | 6 | 5 | 7 | 178 | ||
| Chirag Pasricha | 16 | 4 | 3 | 11 | 9 | 7 | 164 | |
| Flavio Di Nonno | 15 | 1 | 5 | 6 | 3 | 7 | 177 | |
| Paul Munyard | 7 | 3 | 4 | 7 | 11 | 6 | 187 | |
| Daan A M J Hollander | 15 | 120 | 11 | 26 | 6 | 7 | 166 | |
| Leonardo La Serra | 3 | 5 | 14 | 5 | 6 | 22 | ||
| Chloe Fenton | 9 | 1 | 4 | 12 | 19 | 9 | 170 | |
| S. M. Wood | 12 | 1 | 71 | 11 | 20 | 5 | 164 |
All Works
Loading papers...